Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
- Products
-
- Metoprolol Succinate Extended-Release Tablets
- Where it was sold
-
Nationwide in the USA.
Nationwide
- Units affected
- 27,648 100-count Bottles; 5,376 500-count Bottles
- About this recall
- Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,